ArticleArthritis research & therapy2025

Targeting the CXCL12/CXCR4 pathway by an optimized derivative or EPI-X4 preserves chondrocyte function and offers a novel therapeutic approach in rheumatic diseases.

Leonie Ruths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.